In a turbulent market environment, VINC stock has reached its 52-week low, trading at $1.62, with technical indicators from InvestingPro showing the stock in oversold territory. This price level ...

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...

Daniel Hemetsberger narrowly missed out on the downhill podium in fourth place at the Hahnenkamm race in Kitzbühel. However, ...

EST Vincerx Pharma (VINC) files $100M mixed securities shelfInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting ...

After their somewhat lopsided loss to Toronto, Calgary slides two spots in the Power Rankings this week. How much can we ...

SAN MATEO, Calif. - Vincerx Pharma, Inc. (NASDAQ:VINC), a clinical-stage biopharmaceutical company with a current market capitalization of $2.77 million, and Oqory, Inc. announced promising results ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...